
Ritsuko Komaki MD FASTRO, FACR, FARS, FAAWR
Central Nervous System Cancer, Thoracic Cancer
Professor, Radiation Oncology, University of Texas Medical School at Houston
Join to View Full Profile
1515 Holcombe Blvd UT MDACCUnit 97Houston, TX 77030
Phone+1 713-563-2300
Dr. Komaki is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Medical College of Wisconsin Affiliated HospitalsResidency, Radiation Oncology, 1974 - 1978
- Ascension Columbia St. Mary's Milwaukee HospitalInternship, Transitional Year, 1972 - 1973
- OtherClass of 1969
Certifications & Licensure
- TX State Medical License 1992 - 2026
- WI State Medical License 1976 - 2017
- NY State Medical License 1985 - 2007
- American Board of Radiology Radiation Oncology
- American Board of Radiology Therapeutic Radiology
Awards, Honors, & Recognition
- Gold Medalist of ARS in 2022
- Gloria Lupton Tennison Endowed Chair for the Lung Cancer Research at MDACC
Clinical Trials
- Combined Modality Treatment for Resectable Non-Small Cell Superior Sulcus Tumors Start of enrollment: 1993 Oct 01
- High-Dose or Standard-Dose Radiation Therapy and Chemotherapy With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery Start of enrollment: 2007 Nov 01
- CPT-11/Cisplatin and Celecoxib With Radiation Therapy for Patients With Unresectable Non-Small Cell Lung Cancer (NSCLC) Start of enrollment: 2003 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- Comparison of predicted and actual dermatitis generated from computed tomography images and dose distribution maps.Yasuhide Miyabe, Saori Oshiro, Hiroto Seki, Yusuke Muroi, Eriko Kawashima
Technical Innovations & Patient Support in Radiation Oncology. 2024-12-01 - Prognostic Factors in Limited-Stage Small Cell Lung Cancer: A Secondary Analysis of CALGB 30610-RTOG 0538.Michael K Farris, Michael D Mix, Xiaofei Wang, Brandy Jaszewski, Nathan Foster
JAMA Network Open. 2024-10-01 - 3 citationsLong-Term Prospective Outcomes of Intensity Modulated Radiotherapy for Locally Advanced Lung Cancer: A Secondary Analysis of a Randomized Clinical Trial.Stephen G Chun, Chen Hu, Ritsuko U Komaki, Robert D Timmerman, Steven E Schild
JAMA Oncology. 2024-08-01
Grant Support
- RTOG, NRGNCI1988–2018
Committees
- Member, Institutional Board Review at MDACC 1998 - 2018
- Co-Chair, Lung Cancer Committee of RTOG/NRG 1998 - 2018
Research History
- PI of RTOGPI of RTOG from MDACC1990 - 2018
- Section Chief of Thoracic Radiation Oncology at MDACC1988 - 2018
Professional Memberships
- Member
Other Languages
- Japanese
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: